EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles

Betül Giray, Leyla Yurttaş, Zafer Şahin, Barkın Berk, Şeref Demirayak

ACTA Pharmaceutica Sciencia · 2019

DOI: 10.23893/1307-2080.aps.05707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACTA Pharmaceutica Sciencia, 2019. Verfasst von Betül Giray und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial resistance to the treatment of infectious diseases is the main problem. Many classes of antibiotics are facing resistance and have initiated new efforts to develop new derivatives and discover new chemical classes.1 Gram positive and gram-negative bacteria such as Escherichia coli, Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, Bacillus cereus, Pseudomonas aeruginosa etc. are responsible for many diverse infections which even can cause of death.2

Zitieren

APA

Giray, B., Yurttaş, L., Şahin, Z., Berk, B., & Demirayak, Ş. (2019). Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles. ACTA Pharmaceutica Sciencia. https://doi.org/10.23893/1307-2080.aps.05707

Vancouver

Giray B, Yurttaş L, Şahin Z, Berk B, Demirayak Ş. Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles. ACTA Pharmaceutica Sciencia. 2019. doi:10.23893/1307-2080.aps.05707

BibTeX
@article{Giray2019,
  author = {Giray, Betül and Yurttaş, Leyla and Şahin, Zafer and Berk, Barkın and Demirayak, Şeref},
  title = {Antimicrobial evaluation of trisubstituted 2-piperazinyl thiazoles},
  journal = {ACTA Pharmaceutica Sciencia},
  year = {2019},
  doi = {10.23893/1307-2080.aps.05707}
}
Kostenlos starten →